Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

5 High Current Analyst ‘Buys’ – $GRA, $CSH, $FEIC, $HI, $MCRS

Analyst recommendations can be a first step to determining if a stock is worth risking your hard-earned money. At any given time, there are thousands of stocks being recommended, and each for different reasons. The ones on this list have current ratios over 3, quick ratios over 2 and analyst recommendations of buy.

The current ratio indicates the company’s ability to meet short term debt   and other obligations – the higher, the better. A value over 1 means its current assets are worth at least as much as its current liabilities. The quick ratio, or acid test, is much the same only current inventories are subtracted from the company’s current assets before looking at its current liabilities in proportion. Again, the higher the better. The target for this metric will vary considerably between industries but, for the most part, a quick ratio of at least 1 is acceptable.


Cash America International Inc (CSH) is a $1.54B market cap credit services company with a forward P/E ratio of 10.32. CSH has the highest current ratio of the companies we looked at, coming in at 5.51. It also has a high quick ratio of 4.38. CSH has returned 42.64% YTD and has a beta of 1.40. It recently traded at $53.04, 49.74% above its 52-week low. Malcolm Fairbairn’s Ascend Capital had more than $12 million in the company at the end of the second quarter. Jim Simons’ Renaissance Technologies and D.E. Shaw’s D E Shaw are also fans of CSH.

FEI Company (FEIC) is a scientific and technical instruments company with a $1.48B market cap and a 14.99 forward P/E ratio. It has a current ratio of 3.09 and a quick ratio of 2.34. So far this year, FEIC has returned 49.26%. It has a 1.26 beta and recently traded at $39.43, 80.04% above its 52-week low. Chuck Royce’s Royce & Associates was bullish on FEIC at the end of the second quarter, boasting a position worth more than $124 million. Ken Fisher’s Fisher Asset Management and Thomas Steyer’s Farallon Capital also like the company.

Hillenbrand Inc (HI) is a personal services company with a $1.29B market cap. It has a 3.71 current ratio and a 3.05 quick ratio. It has returned 1.58% YTD. HI has a 0.75 beta and recently traded at $21.03, 30.40% above its 52-week low. Ric Dillon’s Diamond Hill Capital had more than $26 million in the company at the end of the second quarter. HI is a favorite of Ken Brodkowitz and Mike Vermut’s Newland Capital, as is D.E. Shaw’s D E Shaw.

MICROS Systems Inc (MCRS) is an application software company with a $3.82B market cap and a 19.56 forward P/E ratio. The company has a 3.05 current ratio and a 2.93 quick ratio. So far this year, MCRS has returned 8.39%. It has a beta of 1.22 and recently traded at $47.98, 25.17% above its 52-week low. At the end of the second quarter, Bill Miller’s Legg Mason Capital Management had over $29 million in the company while Steve Cohen’s Sac Capital Advisors had more than $24 million.

W.R. Grace & Co (GRA) is a specialty chemicals company with a $2.94B market cap and a 9.72 forward P/E ratio. It has a current ratio of 3.07 and a quick ratio of 2.54. GRA has returned 13.41% YTD. The company has a 2.42 beta and recently traded at $40.72 a share, up 34.61% over its 52-week low. James Dinan’s York Capital Management had over $223 million in GRA at the end of the second quarter. Jonathan Auerbach’s Hound Partners and Rehan Jaffer’s H Partners Management also had significant positions in the company.

Biotech Stock Alert - 20% Guaranteed Return in One Year

Hedge Funds and Insiders Are Piling Into

One of 2015's best hedge funds and two insiders snapped up shares of this medical device stock recently. We believe its transformative and disruptive device will storm the $3+ billion market and help it achieve 500%-1000% gains in 3 years.

Get your FREE REPORT and the details of our 20% return guarantee today.

Subscribe me to Insider Monkey's Free Daily Newsletter
This is a FREE report from Insider Monkey. Credit Card is NOT required.
Loading Comments...

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 102% in 3 years!! Wondering How?

Download a complete edition of our newsletter for free!